Skip to main content
Premium Trial:

Request an Annual Quote

KeyGene, Floragenex Extend Licensing Deal

NEW YORK (GenomeWeb) – KeyGene and Floragenex today said they have extended a licensing agreement covering KeyGene's sequence-based genotyping technology. 

As part of the deal, Floragenex, a genomics service provider, will extend its SBG service offerings to include double digest RAD-Seq in non-commercial and academic research across all species. Financial and other terms were not disclosed. 

In late 2012, the companies settled a patent dispute and reached a licensing agreement that allowed Portland, Oregon-based Floragenex to continue applying its Restriction-site Associated DNA method in certain fields.

"Floragenex's expertise, professionalism, and impressive track record with RAD-Seq across a wide range of genomes logically fit with a broader portfolio of SBG service offerings," KeyGene CSO Michiel van Eijk said in a statement. "This will accelerate the understanding of genetic variation in plants, animals, and other organisms in a highly cost-efficient manner."

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.